ABOUT AGO TUMOR

These benefits from the potential randomized research on hypofractionation have internationally led to various assessments and keep on to dominate a controversially led discussion. In copyright and Great Britain, hypofractionated radiation therapy is valued since the ‘new conventional’ and assessed as remaining of equal value to normofractionat